Skip to main content
Equibles

Dennis Resnick

Analyst

Canaccord Genuity

Equibles does not estimate personal net worth.

About Dennis Resnick

Dennis Resnick is recorded as Analyst at Canaccord Genuity. Dennis Resnick has spoken on 1 earnings call across 1 company, most recently for Eton Pharmaceuticals, Inc. on August 13, 2026. The companies whose calls Dennis Resnick spoke on are classified in the Healthcare sector.

Dennis Resnick on recent calls

“So just starting with the recent acquisition of ASM001, just talk a little bit more about the synergies you expect to leverage with the Hemangio franchise and how much of the infrastructure there could help out this product once approved.”
Analyst — Canaccord Genuity, Eton Pharmaceuticals Q2 2026 Earnings Call ·

Affiliation history

  • Canaccord Genuity

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity